Measurable residual disease detection by high-throughput sequencing improves risk stratification for pediatric B-ALLBrent L. Wood, Ilan Kirsch, David Wu et al.|Blood|2017Cited by 227
Evaluation of Plasma Microbial Cell-Free DNA Sequencing to Predict Bloodstream Infection in Pediatric Patients With Relapsed or Refractory CancerKathryn Goggin, Charles Gawad, Veronica Gonzalez-Pena et al.|JAMA Oncology|2019Cited by 130
1756. Prediction of Bloodstream Infection Prior to Onset of Symptoms by Plasma Metagenomic Sequencing in Pediatric Patients With Relapsed or Refractory Malignancy (PREDSEQ)Kathryn Goggin, Joshua Wolf, Yuki Inaba et al.|Open Forum Infectious Diseases|2018Cited by 4
Non-Invasive Prediction of Invasive Fungal Infection By Plasma-Based Microbial Cell-Free DNA Next-Generation Sequencing in Pediatric Patients with Relapsed or Refractory LeukemiaJoshua Wolf, Cara E. Morin, Kathryn Goggin et al.|Transplantation and Cellular Therapy|2021Cited by 1
#75: Microbial Cell-free DNA Sequencing for Prediction of Culture-Negative Infection Events in Children with CancerKathryn Goggin, Joshua Wolf, Amanda griffen et al.|Journal of the Pediatric Infectious Diseases Society|2021Cited by 1